Belgium introduces synchronised procedure guidance for combined clinical trials with medicinal products and device performance or clinical investigations.
FAMHP (Belgian Medicine Agency) · BelgiumFrom 1 September 2026, applicants must use new eAF version 1.28.0.0, aligned with ISO IDMP model and Veterinary Regulation 2019/6.
FAMHP (Belgian Medicine Agency) · BelgiumSince 1 July 2026, animal species must be specified on veterinary prescriptions under the new mandatory model.
FAMHP (Belgian Medicine Agency) · BelgiumImplementing Regulation (EU) 2026/1810 updates the list of essential substances for food-producing horses, entering into force 28 July 2026, with transition until 21 May 2027.
FAMHP (Belgian Medicine Agency) · BelgiumFAMHP and AMCRA offer e-learning to support veterinarians in recording antibiotic use in horses and aquaculture fish via VAMREG from 1 July 2026.
FAMHP (Belgian Medicine Agency) · BelgiumFAMHP reminds patients and healthcare professionals of rational use recommendations for benzodiazepines and related medicines following WOREL guideline publication.
FAMHP (Belgian Medicine Agency) · BelgiumDocument clarifies distinction between revision date and approval date in product information for human medicinal products.
FAMHP (Belgian Medicine Agency) · BelgiumINAMI makes healthcare provider statistics on obligatory health insurance claims available online in interactive form via the ProSanté platform.
INAMI-RIZIV (Belgian HTA) · BelgiumBelgium requires mutual fund authorisation for reimbursement of GLP-1 agonist antidiabetic medicines including Ozempic from 1 February 2026.
INAMI-RIZIV (Belgian HTA) · BelgiumFAMHP launches BioVigilance, an online application for reporting serious adverse events and reactions related to reproductive and non-reproductive substances of human origin intended for human application.
FAMHP (Belgian Medicine Agency) · BelgiumIn order to guarantee a high standard of safety and quality in gamete donations in Belgium and to strengthen the supervision of fertility centres in the long term, the Federal Agency for Medicines and Health Products ...
FAMHP (Belgian Medicine Agency) · BelgiumINAMI-RIZIV publishes a 29-action operational plan detailing its multi-year Appropriate Care strategy to ensure right care, right time, right place, right provider.
INAMI-RIZIV (Belgian HTA) · BelgiumFAMHP updates on pending EU legislative initiatives including the Biotech Act, MDR/IVDR revision, Critical Medicines Act, pharmaceutical legislation and online health information measures.
FAMHP (Belgian Medicine Agency) · BelgiumPRAC completed review of valproate safety signal and recommended new safety information for Ixchiq chikungunya vaccine.
FAMHP (Belgian Medicine Agency) · BelgiumINAMI report on measures to prevent inappropriate billing of emergency supplements for scheduled MRI examinations performed outside standard hours.
INAMI-RIZIV (Belgian HTA) · BelgiumBelgium published a quality indicator for bariatric surgery in September 2023 requiring a minimum 3-month preoperative reflection period; first results are now reported.
INAMI-RIZIV (Belgian HTA) · Belgium10-02-2026 - Nouvelles Le projet pilote “nouveau financement des soins infirmiers à domicile” démarre avec 58 pratiques
INAMI-RIZIV (Belgian HTA) · BelgiumINAMI-RIZIV launches a public awareness campaign encouraging patients to bring their Belgian electronic identity card (eID) to dental appointments.
INAMI-RIZIV (Belgian HTA) · BelgiumFAMHP publishes information on quota exceedances involving foreign gamete donors and emphasises its commitment to transparency and ongoing monitoring.
FAMHP (Belgian Medicine Agency) · BelgiumEMA Pharmacovigilance Risk Assessment Committee initiated review of injectable iron medicines for hypophosphataemia and bone-related adverse effects.
FAMHP (Belgian Medicine Agency) · BelgiumVous utilisez le site de l’INAMI ? Partagez votre expérience lors d’une interview et aidez-nous à construire un site plus clair, plus simple et mieux adapté à vos besoins. Vous utilisez le site de l’INAMI ? Partagez v...
INAMI-RIZIV (Belgian HTA) · BelgiumFAMHP alerts to medication error risk from varied vitamin D3 product strengths and dosages; overdose risk in infants, children and elderly.
FAMHP (Belgian Medicine Agency) · BelgiumSouhaitez-vous mettre votre leadership et votre expertise de médecin au service d'une utilisation optimale du budget de l'assurance soins de santé ? Êtes-vous prêt à jouer un rôle crucial pour veiller à ce que les dis...
INAMI-RIZIV (Belgian HTA) · BelgiumINAMI-RIZIV concludes its 47-consensus-meeting series with results on multiple sclerosis treatment; coordination transfers to KCE for evidence-based practice activities.
INAMI-RIZIV (Belgian HTA) · BelgiumEMA Pharmacovigilance Risk Assessment Committee recommended new safety information for desogestrel- and etonogestrel-containing contraceptives and Litfulo (alopecia areata).
FAMHP (Belgian Medicine Agency) · BelgiumNew version 1.28.0.0 of the Marketing Authorisation Application Form aligns product data with ISO IDMP model and reflects New Veterinary Regulation 2019/6 changes.
FAMHP (Belgian Medicine Agency) · BelgiumFAMHP launches VAMREG, a new application for mandatory collection of data on sales, use and supply of veterinary antibiotics in Belgium.
FAMHP (Belgian Medicine Agency) · Belgium26-02-2026 - Nouvelles Plan Maladies Rares 2026 2030 : un socle pour de nouvelles actions concrètes
INAMI-RIZIV (Belgian HTA) · Belgium13-01-2026 - Nouvelles Médicaments : Davantage d’innovations et d’indications. Quel coût pour l’INAMI en 2024 ?
INAMI-RIZIV (Belgian HTA) · Belgium24-03-2026 - Nouvelles Chiffres d’adhésion aux accords et conventions nationaux entre dispensateurs de soins et mutualités établis par le Comité de l’assurance
INAMI-RIZIV (Belgian HTA) · Belgium13-03-2026 - Nouvelles Chiffres d’adhésion aux accords tarifaires disponibles : accords médecins, dentistes, sages-femmes et logopèdes 2026-2027
INAMI-RIZIV (Belgian HTA) · Belgium29-07-2026 - Dernière réunion de consensus : la prise en charge de la sclérose en plaques
INAMI-RIZIV (Belgian HTA) · Belgium05-03-2026 - Nouvelles Nous recrutons des inspecteurs sociaux : séance d'information le 28 mars 2026
INAMI-RIZIV (Belgian HTA) · BelgiumDistribution restrictions on Zypadhera have been gradually relaxed since 1 January 2026 as availability improves.
FAMHP (Belgian Medicine Agency) · BelgiumAzactam 1 g and 2 g powder are in very limited supply in Belgium; production not expected to resume before July 2027.
FAMHP (Belgian Medicine Agency) · Belgium